Retrieve Medical to Acquire AI Firm Curatus

Published 24/02/2025, 14:38
Retrieve Medical to Acquire AI Firm Curatus

BEDMINSTER, N.J. - Retrieve Medical (TASE:BLWV) Holdings Inc. (RMHI), a Nevada-based healthcare software provider with a market capitalization of $88.34 million and an impressive year-to-date return of 292%, has announced its intent to acquire Curatus LLC, a technology company specializing in artificial intelligence-driven provider data solutions. The acquisition is aimed at bolstering Retrieve’s healthcare offerings by integrating Curatus’s SaaS platform, ProviderLenz, into its network. According to InvestingPro, RMHI maintains excellent financial health, suggesting strong positioning for this strategic move.

The transaction is subject to the finalization of a definitive agreement and the satisfaction of customary closing conditions, including necessary regulatory filings and shareholder approval. Following the acquisition, Curatus is expected to operate as a wholly-owned subsidiary under the continued leadership of its CEO, Mark Fabiano. RMHI’s stock has shown remarkable momentum, with a six-month return of 91%, reflecting investor confidence in the company’s strategic decisions.

ProviderLenz, Curatus’s flagship platform, utilizes AI to aggregate and verify provider credentialing and directory data in real-time. This addresses the significant issue of inaccurate provider data, which contributes to over $100 billion in annual healthcare fraud costs. The acquisition aims to leverage advanced AI tools to automate routine tasks, enhance data analysis, and create tailored solutions that improve customer experiences and operational efficiency.

Retrieve Medical Holdings is known for its software platform, Retrieve Dx™, which uses advanced natural language processing to analyze patient data and assist physicians in diagnosing chronic conditions. This technology is designed to integrate with major electronic medical record systems, including Epic and Oracle (NYSE:ORCL) Cerner (NASDAQ:CERN).

Curatus, co-founded by Cory and Mark Fabiano and Jarrod Mandozzi in 2018, has made strides in provider data management with its AI-powered platform, which was selected in 2024 by a major healthcare IT company for integration with leading healthcare claims platforms.

This strategic move by Retrieve Medical Holdings is expected to position the combined entity to drive growth and offer a competitive edge in the healthcare sector by streamlining technology platforms and reducing administrative overhead. InvestingPro analysis reveals the company has been profitable over the last twelve months, with additional metrics and insights available to subscribers. Discover more detailed financial analysis and 6 additional ProTips by subscribing to InvestingPro today.

The information about this acquisition is based on a press release statement from Retrieve Medical Holdings Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.